Endo International Investor Relations Material
Latest events
Q1 2025
Endo International
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Endo International plc
Access all reports
Endo International plc is a specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription products, as well as over-the-counter medications. The company operates in therapeutic areas such as pain management, urology, and women’s health. Endo serves healthcare providers, pharmacies, and patients with a diverse portfolio of medical solutions. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Key slides for Endo International plc
Q2 2024
Endo International plc
Q1 2024
Endo International plc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ENDP
Country
🇺🇸 United States